Effect of PF-00734200 in Subjects With Type 2 Diabetes

Status:
Completed

Trial end date:
2008-08-01

Target enrollment:

Participant gender:

To determine the effect of PF-00734200 on HbA1c in type 2 diabetic subjects receiving metformin

Phase 2

Pfizer